Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroendocrine Tumors × ibrutinib × 30 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 17 Lymphoma, Non-Hodgkin 6 Lymphoma, Mantle-Cell 6 Lymphoma, Large B-Cell, Diffuse 6 Waldenstrom Macroglobulinemia 3 Neoplasms 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma 3 Recurrence 2 Lymphoma, B-Cell 2 Leukemia, Hairy Cell 2 Burkitt Lymphoma 2 Prostatic Neoplasms, Castration-Resistant 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Myelodysplastic Syndromes 1 Lymphoproliferative Disorders 1 Lymphoma, AIDS-Related 1 Lymphatic Diseases 1 Leukemia, Prolymphocytic 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphoid 1 Leukemia, B-Cell 1 Immunoproliferative Disorders 1 Immune System Diseases 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Bronchiolitis Obliterans Syndrome 1

Interventions

lutetium Lu 177 dotatate 7 cabozantinib 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 olaparib 3 Everolimus 3 lanreotide 2 avelumab 2 X-Rays 2 Phantoms, Imaging 2 Octreotide 2 Nivolumab 2 Lutetium-177 2 surufatinib 1 repotrectinib 1 peposertib 1 pembrolizumab 1 pazopanib 1 gallium Ga 68 dotatate 1 fludarabine 1 belinostat 1 amino-acid, glucose, and electrolyte solution 1 aldesleukin 1 Sunitinib 1 Salts 1 Radiotherapy 1 Ipilimumab 1 Introns 1 Interferon alpha-2 1 Immunoglobulin G 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡